Servier Archives -

Amgen shares down as heart failure drug disappoints in phase 3 trial

https://pharmaphorum.com/news/amgen-shares-down-7-after-heart-failure-drug-disappoints-in-phase-3-trial/

Servier to acquire Danish cancer biotech Symphogen

https://pharmaphorum.com/news/servier-to-acquire-danish-biotech-symphogen/

Servier reveal how they are using data to empower their field force

https://pharmaphorum.com/sales-marketing/servier-reveal-how-they-are-using-data-to-empower-their-field-force/

France’s Servier finally goes on trial over Mediator safety scandal

https://pharmaphorum.com/news/frances-servier-finally-goes-on-trial-over-mediator-safety-scandal/

Servier and Oncodesign announce Parkinson’s R&D tie-up

https://pharmaphorum.com/news/servier-and-oncodesign-announce-parkinsons-rd-tie-up/

Servier expands global footprint post Shire deal

https://pharmaphorum.com/news/servier-expands-footprint-shire/

Shire’s $2.4bn oncology sell-off seen as Takeda spoiler

https://pharmaphorum.com/news/shire-sell-cancer-business-servier-2-4bn/

Safety restrictions spell the end for Servier osteoporosis drug

https://pharmaphorum.com/news/servier-end-production-osteoporosis-drug/

Servier and Pfizer begin trials for off-the-shelf T-cell cancer therapy

https://pharmaphorum.com/news/servier-and-pfizer-car-t/

Search